Reversion of antibiotic resistance by inhibiting mecA in clinical methicillin-resistant Staphylococci by antisense phosphorothioate oligonucleotide.
about
Design, challenge, and promise of stimuli-responsive nanoantibiotics.Antisense antimicrobial therapeuticsFighting against evolution of antibiotic resistance by utilizing evolvable antimicrobial drugs.In vivo efficacy of β-lactam/tripropeptin C in a mouse septicemia model and the mechanism of reverse β-lactam resistance in methicillin-resistant Staphylococcus aureus mediated by tripropeptin C.Mechanism of synergy between SIPI-8294 and β-lactam antibiotics against methicillin-resistant Staphylococcus aureus.Emerging Nanomedicine Therapies to Counter the Rise of Methicillin-Resistant Staphylococcus aureus.
P2860
Reversion of antibiotic resistance by inhibiting mecA in clinical methicillin-resistant Staphylococci by antisense phosphorothioate oligonucleotide.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Reversion of antibiotic resist ...... sphorothioate oligonucleotide.
@en
type
label
Reversion of antibiotic resist ...... sphorothioate oligonucleotide.
@en
prefLabel
Reversion of antibiotic resist ...... sphorothioate oligonucleotide.
@en
P2093
P2860
P356
P1476
Reversion of antibiotic resist ...... sphorothioate oligonucleotide.
@en
P2093
Gonghao He
Jingru Meng
Mingkai Li
Xiaoxing Luo
Xiaoyan Xue
P2860
P2888
P304
P356
10.1038/JA.2014.132
P577
2014-10-01T00:00:00Z
P6179
1021252359